Lima Hui BioConsulting, LLC
  • Home
  • LinkedIn
  • More
    • Home
    • LinkedIn
Lima Hui BioConsulting, LLC
  • Home
  • LinkedIn

Lima Hui BioConsulting

Lima Hui BioConsultingLima Hui BioConsultingLima Hui BioConsulting

Turbocharge Your T Cell-Based Preclinical Programs

Contact Us

Lima Hui BioConsulting

Lima Hui BioConsultingLima Hui BioConsultingLima Hui BioConsulting

Turbocharge Your T Cell-Based Preclinical Programs

Contact Us

Preclinical Development of T Cell Engager, CAR-T, TCR-T

Optimize Your R&D Power

Research shows teams perform best with 5-7 members. How many members are on your R&D leadership team? Lima Hui can efficiently provide the additional expertise your team needs.

Streamline drug candidate selection & characterization for IND

Strategically expedite and stress test your programs.

Greater confidence in strategic and scientific decision-making

Analyze primary scientific papers, conference reports, patents, etc., pertinent to your drug candidates or platforms.

Boost business development potential

Tailor your preclinical data packages for high business impact.

About Lima Hui BioConsulting

Our Mission

Our Mission

Our Mission

Catalyze R&D for biotech leaders with our exceptional capabilities


Harness the curative potential of T cells

Our Values

Our Mission

Our Mission

Your Success = Our Success


Provide high value services with integrity, resourcefulness, and scientific rigor

 

Case Study

 

Client's business challenge

  • Needed to acquire and analyze 10-20 patient samples in order to gain clinical insights and to decide their research strategy
  • The estimated time required for acquiring and analyzing 10-20 patient samples could cause a significant delay in the product development timeline

Lima Hui's solution

  • Summarized findings from 265+ patient samples through a curated set of peer-reviewed publications
  • Generated clinical insights from the data summary pertinent to the client's research question
  • Provided recommendations for the client's research strategy based on the clinical insights
  • Prepared high-level summary slides to streamline the client's communication with investors

Results

  • Because the amount of clinical data summarized was significantly larger than the initially proposed 10-20 sample size, the client felt highly confident about the decision made based on Lima Hui's report and recommendations.
  • Investors' research inquiry was successfully addressed without acquiring patient samples
  • Product development timeline was unaffected

Frequently Asked Questions

 Contact us to fast track your endeavors


Strengthen your preclinical research programs


  • Analyze the information relevant to your T cell engager, CAR-T, TCR-T program.


  • Review your hypotheses, strategies, timelines, milestones, critical vs optional activities, go/no-go decisions, risk mitigation options, etc. 



Stay ahead of the curve with insights into the competitive landscape


  • Customized analyses of assets and products that might compete with your drug candidate. 



Seeking another sharp eye for your crucial presentation?


  • Review and polish your slide deck for impactful presentation to diverse stakeholders.



Maximize your influence


  • Champion your initiatives within individual departments or across functional teams.



Please contact us for services not listed. We have a knack for unconventional problem-solving.


Post-PhD scientific leadership (15 years)


  • Screen and characterize CAR (mono-specific and beyond), TCR, and next generation T cell modification candidates.


  • Develop and optimize in vitro assays and indication-relevant in vivo mouse tumor models.


  • Evaluate drug candidate competitiveness through synthesis of relevant information, e.g. primary literature, conference reports, patents, FDA guidelines.


  • Present research strategy and data packages to key stakeholders, both internal and external.



Cross-functional program team leadership and management at small and global biotechs (8 years)


  • Apply a variety of leadership approaches and project management methodologies.


  • Schedule and conduct meeting series. Provide timely and informative post-meeting summaries. 


  • Generate and maintain program specific dashboards and timelines.


  • Align stakeholders regarding deliverables, strategies, progress, risks, etc.



Customized-configuration of Benchling electronic lab notebook and inventory management (3 years)


  • Design and refine Schemas.


  • Code SQL live dashboard for meta-analyses and inventory tracking.


  • Liaise between end users and Benchling for complex projects and structured user training.



Contact us for more information

 

  • Client first 
  • Nimble, analytical, and methodical problem-solving 
  • Authentic, reflective in word and deed


We can be your creative and resourceful ally who bolsters your team's capacity to solve complex problems.


We have first-hand understanding of the advantages and constraints at small and global biotech companies. We will quickly get on the same page and start problem-solving with you.


"Lima" and "Hui" in Hawaiian mean "Hand" and "Combine", respectively. 


"Lima Hui" embodies our mission to provide clients with enriching strategic thought partnership.

Chia-Yung Wu, PhD, DASM is the founder and full-time member. We sub-contract to other expert consultants as needed.


Contact Us

We take privacy seriously and will not distribute your contact info.

Attachment (10Mb/file)
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Curated Industry Updates

 

See our posts on LinkedIn

If you want to go fast, go alone. If you want to go far, go together. If you want to go fast and far, add Lima Hui to your team.

African Proverb, appended :-)

Copyright © 2024 Lima Hui BioConsulting, LLC - All Rights Reserved.

Stock images from Vecteezy & GoDaddy.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept